Related Experiment Video

Updated: Jun 10, 2025

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay
12:26

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay

Published on: May 3, 2018

18.6K

Emerging roles of cyclin-dependent kinase 7 in health and diseases

Mahder Dawit Belew1, Jingrui Chen1, Zhaokang Cheng1

  • 1Department of Pharmaceutical Sciences, Washington State University, 412 E. Spokane Falls Blvd., Spokane, WA 99202-2131, USA.

Trends in Molecular Medicine
|October 16, 2024
PubMed

Insights

Cyclin-dependent kinase 7 (CDK7) inhibitors show promise for cancer treatment. This review explores CDK7

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Pharmacology

Background:

  • Cyclin-dependent kinase 7 (CDK7) is crucial for cell cycle progression and transcription, processes vital for cancer development.
  • CDK7 inhibitors demonstrate significant anticancer effects in preclinical research and are under clinical investigation.
  • Despite CDK7's broad expression, its effects on normal tissues are understudied.

Purpose of the Study:

  • To review the biological functions of CDK7.
  • To explore its roles in development, homeostasis, and disease.
  • To discuss CDK7 regulation, substrates, and future research directions.

Main Methods:

  • Literature review of CDK7's biological functions.
  • Analysis of CDK7's regulatory mechanisms and kinase activation.
  • Compilation of identified CDK7 substrates.

Main Results:

  • CDK7 plays central roles in cell cycle and transcription.
  • CDK7 inhibitors exhibit anticancer activities.
  • Limited attention has been paid to CDK7 inhibition's impact on normal tissues.

Conclusions:

  • A comprehensive understanding of CDK7 is essential for developing effective and safe CDK7 inhibitors.
  • Further research is needed to address unanswered questions regarding CDK7's functions and inhibition effects.
  • Minimizing adverse effects of CDK7 inhibitors requires deeper insights into its roles in normal physiology.
Keywords:
CDK7organ developmentpathologyphysiologytissue homeostasis

More Related Videos

Experimental Approaches to Study Mitochondrial Localization and Function of a Nuclear Cell Cycle Kinase, Cdk113:15

Experimental Approaches to Study Mitochondrial Localization and Function of a Nuclear Cell Cycle Kinase, Cdk1

Published on: February 25, 2016

11.8K
Identification of Novel CK2 Kinase Substrates Using a Versatile Biochemical Approach11:11

Identification of Novel CK2 Kinase Substrates Using a Versatile Biochemical Approach

Published on: February 21, 2019

7.3K

Related Concept Videos

M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.5K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
5.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K